Melanotic neuroectodermal tumor of infancy: Report of a case with myogenic differentiation

Pediatric and Developmental Pathology

Volumn 10, Issue 2, 2007, Pages 157-160

  Ellison, Dale A ^a   Adada, Badih ^a   Qualman, Stephen J ^b   Parham, David M ^c  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b NATIONWIDE CHILDREN S HOSPITAL   (United States)

^c ARKANSAS CHILDREN S HOSPITAL   (United States)

Author keywords

Melanotic neuroectodermal tumor of infancy; MNTI; Myogenin

Indexed keywords

ANAMNESIS; ARTICLE; CASE REPORT; CRANIOTOMY; HISTOPATHOLOGY; HUMAN; INFANT; MALE; MUSCLE DEVELOPMENT; NEUROECTODERM TUMOR; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SKULL RADIOGRAPHY;

FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT; KERATINS; MALE; MYOGENIN; NEOPLASM PROTEINS; NEUROECTODERMAL TUMOR, MELANOTIC; PHOSPHOPYRUVATE HYDRATASE; SKULL NEOPLASMS; TIME FACTORS; TREATMENT OUTCOME;

EID: 34147192611     PISSN: 10935266     EISSN: 16155742     Source Type: Journal    
DOI: 10.2350/06-07-0138.1     Document Type: Article

References (10)

1. Dehner LP, Sibley RK, Sauk JJ Jr, et al. Malignant melanotic neuroectodermal tumor of infancy: a clinical, pathologic, ultrastructural and tissue culture study. Cancer 1979;43:1389-1410.
2. Pettinato G, Manivel JC, d'Amore ES, Jaszcz W, Gorlin RJ. Melanotic neuroectodermal tumor of infancy: a reexamination of a histogenetic problem based on immunohistochemical, flow cytometric, and ultrastructural study of 10 cases. Am J Surg Pathol 1991;15: 233-245.
3. Kapadia SB, Frisman DM. Hitchcock CL, Ellis GL, Popek EJ. Melanotic neuroectodermal tumor of infancy: clinicopathological, immunohistochemical, and flow cytometric study. Am J Surg Pathol 1993;17:566-573.
4. Kumar S, Perlman E, Harris CA, Raffeld M, Tsokos M. Myogenin is a specific marker for rhabdomyosarcoma: an immunohistochemical study in paraffin-embedded tissues. Mod Pathol 2000;13:988-993.
5. Cessna MH, Zhou H, Perkins SL, et al. Are myogenin and myoD1 expression specific for rhabdomyosarcoma? A study of 150 cases, with emphasis on spindle cell mimics. Am J Surg Pathol 2001;25: 1150-1157.
6. Eusebi V, Damiani S, Pasquinelli G, Lorenzini P, Reuter VE, Rosai J. Small cell neuroendocrine carcinoma with skeletal muscle differentiation: report of three cases. Am J Surg Pathol 2000;24:223-230.
7. Jones NC, Trainor PA. Role of morphogens in neural crest cell determination. J Neurobiol 2005;64:388-404.
8. Delfini MC, Duprez D. Ectopic Myf5 or MyoD prevents the neuronal differentiation program in addition to inducing skeletal muscle differentiation, in the chick neural tube. Development 2004;131:713-723.
9. Dickman PS, Barmada M, Gollin SM, Blatt J. Malignancy after retinoblastoma: secondary cancer or recurrence? Hum Pathol 1997; 28:200-205.
10. Shah RV, Jambhekar NA, Rana DN, et al. Melanotic neuroectodermal tumor of infancy: report of a case with ganglionic differentiation. J Surg Oncol 1994;55:65-68.